Global Chronic Liver Diseases Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 128 pages | ID: G312F6D90D1FEN
LP Information

Abstracts

According to this study, the global Chronic Liver Diseases Therapeutics market size will reach US$ million by 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Chronic Liver Diseases Therapeutics Industry Forecast” looks at past sales and reviews total world Chronic Liver Diseases Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Chronic Liver Diseases Therapeutics sales for 2025 through 2031. With Chronic Liver Diseases Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Liver Diseases Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Chronic Liver Diseases Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chronic Liver Diseases Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Liver Diseases Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Liver Diseases Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Liver Diseases Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Liver Diseases Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chemotherapy Drugs
• Targeted Therapy
• Vaccines
• Antiviral Drugs
• Immunoglobulins
• Corticosteroids
• Others

Segmentation by Application:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Astellas Pharma
• Bristol-Myers Squibb
• Gilead Sciences
• GlaxoSmithKline
• F. Hoffmann-La Roche
• Merck
• Novartis
• Sanofi
• Pfizer
• Takeda Pharmaceutical
• Bausch Health
• Theratechnologies
• Alnylam Pharmaceuticals
• Protagonist Therapeutics
• Dicerna Pharmaceuticals
• Endo International
• Provectus Biopharmaceuticals
• MAX BioPharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chronic Liver Diseases Therapeutics Market Size (2020-2031)
  2.1.2 Chronic Liver Diseases Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Chronic Liver Diseases Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Chronic Liver Diseases Therapeutics Segment by Type
  2.2.1 Chemotherapy Drugs
  2.2.2 Targeted Therapy
  2.2.3 Vaccines
  2.2.4 Antiviral Drugs
  2.2.5 Immunoglobulins
  2.2.6 Corticosteroids
  2.2.7 Others
2.3 Chronic Liver Diseases Therapeutics Market Size by Type
  2.3.1 Chronic Liver Diseases Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Chronic Liver Diseases Therapeutics Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Chronic Liver Diseases Therapeutics Market Size by Application
  2.5.1 Chronic Liver Diseases Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2020-2025)

3 CHRONIC LIVER DISEASES THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Chronic Liver Diseases Therapeutics Market Size Market Share by Player
  3.1.1 Global Chronic Liver Diseases Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Chronic Liver Diseases Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CHRONIC LIVER DISEASES THERAPEUTICS BY REGION

4.1 Chronic Liver Diseases Therapeutics Market Size by Region (2020-2025)
4.2 Global Chronic Liver Diseases Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chronic Liver Diseases Therapeutics Market Size Growth (2020-2025)
4.4 APAC Chronic Liver Diseases Therapeutics Market Size Growth (2020-2025)
4.5 Europe Chronic Liver Diseases Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Chronic Liver Diseases Therapeutics Market Size by Country (2020-2025)
5.2 Americas Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025)
5.3 Americas Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chronic Liver Diseases Therapeutics Market Size by Region (2020-2025)
6.2 APAC Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025)
6.3 APAC Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2020-2025)
7.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025)
7.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chronic Liver Diseases Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CHRONIC LIVER DISEASES THERAPEUTICS MARKET FORECAST

10.1 Global Chronic Liver Diseases Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Chronic Liver Diseases Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Chronic Liver Diseases Therapeutics Forecast
  10.1.3 APAC Chronic Liver Diseases Therapeutics Forecast
  10.1.4 Europe Chronic Liver Diseases Therapeutics Forecast
  10.1.5 Middle East & Africa Chronic Liver Diseases Therapeutics Forecast
10.2 Americas Chronic Liver Diseases Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Chronic Liver Diseases Therapeutics Forecast
  10.2.2 Canada Market Chronic Liver Diseases Therapeutics Forecast
  10.2.3 Mexico Market Chronic Liver Diseases Therapeutics Forecast
  10.2.4 Brazil Market Chronic Liver Diseases Therapeutics Forecast
10.3 APAC Chronic Liver Diseases Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Chronic Liver Diseases Therapeutics Market Forecast
  10.3.2 Japan Market Chronic Liver Diseases Therapeutics Forecast
  10.3.3 Korea Market Chronic Liver Diseases Therapeutics Forecast
  10.3.4 Southeast Asia Market Chronic Liver Diseases Therapeutics Forecast
  10.3.5 India Market Chronic Liver Diseases Therapeutics Forecast
  10.3.6 Australia Market Chronic Liver Diseases Therapeutics Forecast
10.4 Europe Chronic Liver Diseases Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Chronic Liver Diseases Therapeutics Forecast
  10.4.2 France Market Chronic Liver Diseases Therapeutics Forecast
  10.4.3 UK Market Chronic Liver Diseases Therapeutics Forecast
  10.4.4 Italy Market Chronic Liver Diseases Therapeutics Forecast
  10.4.5 Russia Market Chronic Liver Diseases Therapeutics Forecast
10.5 Middle East & Africa Chronic Liver Diseases Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Chronic Liver Diseases Therapeutics Forecast
  10.5.2 South Africa Market Chronic Liver Diseases Therapeutics Forecast
  10.5.3 Israel Market Chronic Liver Diseases Therapeutics Forecast
  10.5.4 Turkey Market Chronic Liver Diseases Therapeutics Forecast
10.6 Global Chronic Liver Diseases Therapeutics Forecast by Type (2026-2031)
10.7 Global Chronic Liver Diseases Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Chronic Liver Diseases Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 Astellas Pharma
  11.1.1 Astellas Pharma Company Information
  11.1.2 Astellas Pharma Chronic Liver Diseases Therapeutics Product Offered
  11.1.3 Astellas Pharma Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Astellas Pharma Main Business Overview
  11.1.5 Astellas Pharma Latest Developments
11.2 Bristol-Myers Squibb
  11.2.1 Bristol-Myers Squibb Company Information
  11.2.2 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product Offered
  11.2.3 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bristol-Myers Squibb Main Business Overview
  11.2.5 Bristol-Myers Squibb Latest Developments
11.3 Gilead Sciences
  11.3.1 Gilead Sciences Company Information
  11.3.2 Gilead Sciences Chronic Liver Diseases Therapeutics Product Offered
  11.3.3 Gilead Sciences Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Gilead Sciences Main Business Overview
  11.3.5 Gilead Sciences Latest Developments
11.4 GlaxoSmithKline
  11.4.1 GlaxoSmithKline Company Information
  11.4.2 GlaxoSmithKline Chronic Liver Diseases Therapeutics Product Offered
  11.4.3 GlaxoSmithKline Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline Main Business Overview
  11.4.5 GlaxoSmithKline Latest Developments
11.5 F. Hoffmann-La Roche
  11.5.1 F. Hoffmann-La Roche Company Information
  11.5.2 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product Offered
  11.5.3 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 F. Hoffmann-La Roche Main Business Overview
  11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Chronic Liver Diseases Therapeutics Product Offered
  11.6.3 Merck Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Novartis
  11.7.1 Novartis Company Information
  11.7.2 Novartis Chronic Liver Diseases Therapeutics Product Offered
  11.7.3 Novartis Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Novartis Main Business Overview
  11.7.5 Novartis Latest Developments
11.8 Sanofi
  11.8.1 Sanofi Company Information
  11.8.2 Sanofi Chronic Liver Diseases Therapeutics Product Offered
  11.8.3 Sanofi Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Sanofi Main Business Overview
  11.8.5 Sanofi Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Chronic Liver Diseases Therapeutics Product Offered
  11.9.3 Pfizer Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Takeda Pharmaceutical
  11.10.1 Takeda Pharmaceutical Company Information
  11.10.2 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product Offered
  11.10.3 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Takeda Pharmaceutical Main Business Overview
  11.10.5 Takeda Pharmaceutical Latest Developments
11.11 Bausch Health
  11.11.1 Bausch Health Company Information
  11.11.2 Bausch Health Chronic Liver Diseases Therapeutics Product Offered
  11.11.3 Bausch Health Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Bausch Health Main Business Overview
  11.11.5 Bausch Health Latest Developments
11.12 Theratechnologies
  11.12.1 Theratechnologies Company Information
  11.12.2 Theratechnologies Chronic Liver Diseases Therapeutics Product Offered
  11.12.3 Theratechnologies Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Theratechnologies Main Business Overview
  11.12.5 Theratechnologies Latest Developments
11.13 Alnylam Pharmaceuticals
  11.13.1 Alnylam Pharmaceuticals Company Information
  11.13.2 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product Offered
  11.13.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Alnylam Pharmaceuticals Main Business Overview
  11.13.5 Alnylam Pharmaceuticals Latest Developments
11.14 Protagonist Therapeutics
  11.14.1 Protagonist Therapeutics Company Information
  11.14.2 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product Offered
  11.14.3 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Protagonist Therapeutics Main Business Overview
  11.14.5 Protagonist Therapeutics Latest Developments
11.15 Dicerna Pharmaceuticals
  11.15.1 Dicerna Pharmaceuticals Company Information
  11.15.2 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product Offered
  11.15.3 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Dicerna Pharmaceuticals Main Business Overview
  11.15.5 Dicerna Pharmaceuticals Latest Developments
11.16 Endo International
  11.16.1 Endo International Company Information
  11.16.2 Endo International Chronic Liver Diseases Therapeutics Product Offered
  11.16.3 Endo International Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Endo International Main Business Overview
  11.16.5 Endo International Latest Developments
11.17 Provectus Biopharmaceuticals
  11.17.1 Provectus Biopharmaceuticals Company Information
  11.17.2 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product Offered
  11.17.3 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Provectus Biopharmaceuticals Main Business Overview
  11.17.5 Provectus Biopharmaceuticals Latest Developments
11.18 MAX BioPharma
  11.18.1 MAX BioPharma Company Information
  11.18.2 MAX BioPharma Chronic Liver Diseases Therapeutics Product Offered
  11.18.3 MAX BioPharma Chronic Liver Diseases Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 MAX BioPharma Main Business Overview
  11.18.5 MAX BioPharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Chronic Liver Diseases Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Chronic Liver Diseases Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chemotherapy Drugs
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Vaccines
Table 6. Major Players of Antiviral Drugs
Table 7. Major Players of Immunoglobulins
Table 8. Major Players of Corticosteroids
Table 9. Major Players of Others
Table 10. Chronic Liver Diseases Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 12. Global Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2020-2025)
Table 13. Chronic Liver Diseases Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 15. Global Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2020-2025)
Table 16. Global Chronic Liver Diseases Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 17. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Player (2020-2025)
Table 18. Chronic Liver Diseases Therapeutics Key Players Head office and Products Offered
Table 19. Chronic Liver Diseases Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Chronic Liver Diseases Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 23. Global Chronic Liver Diseases Therapeutics Market Size Market Share by Region (2020-2025)
Table 24. Global Chronic Liver Diseases Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas Chronic Liver Diseases Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas Chronic Liver Diseases Therapeutics Market Size Market Share by Country (2020-2025)
Table 28. Americas Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 29. Americas Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2020-2025)
Table 30. Americas Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2020-2025)
Table 32. APAC Chronic Liver Diseases Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC Chronic Liver Diseases Therapeutics Market Size Market Share by Region (2020-2025)
Table 34. APAC Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 35. APAC Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe Chronic Liver Diseases Therapeutics Market Size Market Share by Country (2020-2025)
Table 38. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 39. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 42. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Chronic Liver Diseases Therapeutics
Table 44. Key Market Challenges & Risks of Chronic Liver Diseases Therapeutics
Table 45. Key Industry Trends of Chronic Liver Diseases Therapeutics
Table 46. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 47. Global Chronic Liver Diseases Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 48. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 49. Global Chronic Liver Diseases Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 50. Astellas Pharma Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 51. Astellas Pharma Chronic Liver Diseases Therapeutics Product Offered
Table 52. Astellas Pharma Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Astellas Pharma Main Business
Table 54. Astellas Pharma Latest Developments
Table 55. Bristol-Myers Squibb Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 56. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product Offered
Table 57. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bristol-Myers Squibb Main Business
Table 59. Bristol-Myers Squibb Latest Developments
Table 60. Gilead Sciences Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 61. Gilead Sciences Chronic Liver Diseases Therapeutics Product Offered
Table 62. Gilead Sciences Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Latest Developments
Table 65. GlaxoSmithKline Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 66. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product Offered
Table 67. GlaxoSmithKline Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. GlaxoSmithKline Main Business
Table 69. GlaxoSmithKline Latest Developments
Table 70. F. Hoffmann-La Roche Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 71. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product Offered
Table 72. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. F. Hoffmann-La Roche Main Business
Table 74. F. Hoffmann-La Roche Latest Developments
Table 75. Merck Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 76. Merck Chronic Liver Diseases Therapeutics Product Offered
Table 77. Merck Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Merck Main Business
Table 79. Merck Latest Developments
Table 80. Novartis Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 81. Novartis Chronic Liver Diseases Therapeutics Product Offered
Table 82. Novartis Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Sanofi Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 86. Sanofi Chronic Liver Diseases Therapeutics Product Offered
Table 87. Sanofi Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Pfizer Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 91. Pfizer Chronic Liver Diseases Therapeutics Product Offered
Table 92. Pfizer Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Takeda Pharmaceutical Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 96. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product Offered
Table 97. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Takeda Pharmaceutical Main Business
Table 99. Takeda Pharmaceutical Latest Developments
Table 100. Bausch Health Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 101. Bausch Health Chronic Liver Diseases Therapeutics Product Offered
Table 102. Bausch Health Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Bausch Health Main Business
Table 104. Bausch Health Latest Developments
Table 105. Theratechnologies Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 106. Theratechnologies Chronic Liver Diseases Therapeutics Product Offered
Table 107. Theratechnologies Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Theratechnologies Main Business
Table 109. Theratechnologies Latest Developments
Table 110. Alnylam Pharmaceuticals Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 111. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product Offered
Table 112. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Alnylam Pharmaceuticals Main Business
Table 114. Alnylam Pharmaceuticals Latest Developments
Table 115. Protagonist Therapeutics Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 116. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product Offered
Table 117. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Protagonist Therapeutics Main Business
Table 119. Protagonist Therapeutics Latest Developments
Table 120. Dicerna Pharmaceuticals Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 121. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product Offered
Table 122. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Dicerna Pharmaceuticals Main Business
Table 124. Dicerna Pharmaceuticals Latest Developments
Table 125. Endo International Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 126. Endo International Chronic Liver Diseases Therapeutics Product Offered
Table 127. Endo International Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Endo International Main Business
Table 129. Endo International Latest Developments
Table 130. Provectus Biopharmaceuticals Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 131. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product Offered
Table 132. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Provectus Biopharmaceuticals Main Business
Table 134. Provectus Biopharmaceuticals Latest Developments
Table 135. MAX BioPharma Details, Company Type, Chronic Liver Diseases Therapeutics Area Served and Its Competitors
Table 136. MAX BioPharma Chronic Liver Diseases Therapeutics Product Offered
Table 137. MAX BioPharma Chronic Liver Diseases Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. MAX BioPharma Main Business
Table 139. MAX BioPharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Chronic Liver Diseases Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chronic Liver Diseases Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Chronic Liver Diseases Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Chronic Liver Diseases Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Chronic Liver Diseases Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Chronic Liver Diseases Therapeutics Market Size Market Share by Type in 2024
Figure 10. Chronic Liver Diseases Therapeutics in Hospital Pharmacies
Figure 11. Global Chronic Liver Diseases Therapeutics Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Chronic Liver Diseases Therapeutics in Retail Pharmacies
Figure 13. Global Chronic Liver Diseases Therapeutics Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 14. Chronic Liver Diseases Therapeutics in Online Pharmacies
Figure 15. Global Chronic Liver Diseases Therapeutics Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Chronic Liver Diseases Therapeutics Market Size Market Share by Application in 2024
Figure 17. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Player in 2024
Figure 18. Global Chronic Liver Diseases Therapeutics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Chronic Liver Diseases Therapeutics Market Size 2020-2025 ($ millions)
Figure 20. APAC Chronic Liver Diseases Therapeutics Market Size 2020-2025 ($ millions)
Figure 21. Europe Chronic Liver Diseases Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Americas Chronic Liver Diseases Therapeutics Value Market Share by Country in 2024
Figure 24. United States Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Chronic Liver Diseases Therapeutics Market Size Market Share by Region in 2024
Figure 29. APAC Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2020-2025)
Figure 31. China Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Chronic Liver Diseases Therapeutics Market Size Market Share by Country in 2024
Figure 38. Europe Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Chronic Liver Diseases Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 54. APAC Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 55. Europe Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. United States Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Canada Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. China Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Japan Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. Korea Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. India Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Australia Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. Germany Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. France Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. UK Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. Italy Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. Russia Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Israel Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Global Chronic Liver Diseases Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Chronic Liver Diseases Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Chronic Liver Diseases Therapeutics Market Size 2026-2031 ($ millions)